Regular Article
Genetics of inflammatory bowel disease: scientific and clinical implications

https://doi.org/10.1053/bega.2002.0349Get rights and content

Abstract

Considerable progress has been made in the last decade in studies of the genetics of the inflammatory bowel diseases, Crohn's disease and ulcerative colitis. Epidemiological data, notably concordance rates in twin pairs and sibling pairs, have provided strong evidence for the importance of the genetic contribution, particularly in Crohn's disease. These observations provided the catalyst for laboratory-based studies of the molecular genetics of Crohn's disease and ulcerative colitis around the world. The complementary strategies of genome-wide scanning and candidate gene-directed studies have led to the identification of a number of genetic markers which appear to predict disease susceptibility and behaviour.

The identification of the IBD1 gene on chromosome 16 as NOD-2 is unquestionably an important scientific discovery. Although many issues with respect to gene function and expression remain to be resolved there is great optimism that important clinical applications will directly result.

References (52)

  • T Orchard et al.

    Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease

    Gastroenterology

    (2000)
  • K Sugimura et al.

    Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis

    Human Immunology

    (1993)
  • K Negoro et al.

    Crohn's disease is associated with novel polymorphisms in the 5′ flanking region of the tumour necrosis gene

    Gastroenterology

    (1999)
  • R Duerr et al.

    High-density genome scan in Crohn's disease shows confirmed linkage to chromosome 14q11-12

    American Journal of Human Genetics

    (2000)
  • S Vermeire et al.

    Replication of linkage on 14q11-12 in inflammatory bowel disease

    Gastroenterology

    (2000)
  • JD Rioux et al.

    Genome search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci

    American Journal of Human Genetics

    (2000)
  • JF Colombel et al.

    Genotypic analysis of thiopurine 5-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

    Gastroenterology

    (2000)
  • S Shivananda et al.

    Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)

    Gut

    (1996)
  • J Satsangi et al.

    Clinical patterns of familial inflammatory bowel disease

    Gut

    (1996)
  • RK Sellon et al.

    Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin 10 deficient mice

    Infection and Immunity

    (1998)
  • JP Hugot et al.

    Mapping of a susceptibility locus for Crohn's disease on chromosome 16

    Nature

    (1996)
  • Y Ogura et al.

    A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

    Nature

    (2001)
  • BB Crohn et al.

    Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer

    Journal of the American Medical Association

    (1984)
  • C Tysk et al.

    Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking

    Gut

    (1988)
  • M Orholm et al.

    Inflammatory bowel disease in a Danish twin register

    Gut

    (1996)
  • Cited by (57)

    • Differences in monozygotic twins: the implications of diet and intestinal microbioma

      2020, Developmental and Fetal Origins of Differences in Monozygotic Twins: From Genetics to Environmental Factors
    • Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases

      2014, Journal of Controlled Release
      Citation Excerpt :

      Genomic abnormalities are alternate focal points in understanding development of IBD and devising modalities for potential therapeutic targets. Genome wide screening with microsatellite markers has revealed 10 genomic sites that have been implicated in altering the course of both forms of IBD [20]. Caspase recruitment domain family, member 15 (CARD15) (aka nucleotide-binding oligomerization domain 2; NOD2) was the first IBD specific gene located on chromosome 16 to be identified and is therefore popularly called IBD-1.

    • Angiopoietins in inflammation and their implication in the development of inflammatory bowel disease. A review

      2014, Journal of Crohn's and Colitis
      Citation Excerpt :

      Inflammatory bowel disease (IBD) is a chronic inflammatory disorder that encompasses two different clinical entities: Crohn's disease (CD) and ulcerative colitis (UC) 1,2.

    • Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn's disease activity

      2010, Clinical Nutrition
      Citation Excerpt :

      Crohn’s disease (CD) is a chronic inflammatory disease characterized by a transmural and discontinuous inflammation of the intestinal wall. Although the precise etiology of this disease is unknown, most authors believe that the on-going inflammation results from the interaction between genetic and environmental factors, namely bacterial flora and luminal nutrients.1,2 Among the most probably involved pathogenetic mechanisms is the imbalance between proinflammatory and anti-inflammatory cytokines as well as the resistance of the inflammatory cells to apoptotic stimuli.3,4

    • The role of FAS gene variants in inflammatory bowel disease

      2020, Turkish Journal of Gastroenterology
    View all citing articles on Scopus
    View full text